Systech Europe(TM) Announces Rapid Expansion of Customer Base and Pharmaceutical Serialisation Partners Ready to Meet the FMD Regulation

Food and Healthcare Press Releases Friday January 12, 2018 14:00
BRUSSELS--12 Jan--PRNewswire/InfoQuest

Systech International , the global technology leader in serialisation, track and trace, and brand protection grew its European presence in 2017 by 50% with new accounts in France, Germany, Greece, Turkey, and Finland.

The company also added new Authorized Solution Partners to its global network offering integrated turnkey solutions with Systech UniSeries (TM), the industry standard for serialising products to meet the Falsified Medicines Directive (FMD), as well as the Company's expanding track and trace and anti-counterfeiting technologies.

Systech deployed the world's first serialisation and aggregation project in Europe over a decade ago and has now implemented serialisation for 19 of the top 20 global pharmaceutical companies. With 30 years of industry experience, Systech utilizes award-winning configurable software technology, including vision, serialisation workflow, and number management to ensure delivery of quick and cost-effective serialisation solutions to large and small pharmaceutical companies, including multinationals, regional manufacturers, and CMO/CPO's.

Alastair Taylor , Director of European Sales for Systech says, "We're helping customers meet the February 2019 regulation deadline and maintain compliance in a way that's efficient and minimally disruptive. We deliver software and services with packaging equipment (OEM) agnostic solutions, allowing us to work with any partner and any packaging line, whether new or retrofitted."

Servicepoint Oy , one of Systech's sales and integration partners, is implementing Systech's serialisation solution in Finland for Santen Pharmaceutical, the leading Northern European ophthalmic drug manufacturer. The implementation includes Systech serialisation software integrated with packaging machinery by Inno4Life , also a Systech partner.

Matti Rosengren, Vice President, Manufacturing EMEA from Santen says, "Servicepoint is delivering a rapid deployment, pre-configured Systech serialisation module by this summer, well within our budget and timeline, and we are benefitting from a streamlined site integration and validation process."

"Servicepoint is one of few European suppliers able to provide a complete, integrated, serialisation solution to pharmaceutical packaging lines, including consulting, design, build, installation, testing, and maintenance," says Pekka Hoffren, CEO, Servicepoint.

About Systech International:

Systech provides expedited regulatory compliance and has more than 4,000 software implementations in 35 countries. Global Authorized Solution Partners stand ready to assist companies in meeting their country's regulatory deadline and countries of export. Systech and its partner network ensure tight integration of a serialisation solution, facilitated data communication, and decreased overall project risk.

Contact:
Systech International
Stacey Owens-Perrotta
T +1 609 235 3639
stacey.owens-perrotta@SystechOne.com

Latest Press Release

ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA

At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. (Photo: https://mma.prnewswire.com/media/696385/WHA_Global_Health_Agenda.jpg ) ESMO advocated the strengthening of health...

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda(R)

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European...

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation...

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan....

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed...

Related Topics